Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
DDTL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
CSTB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GNAI3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIC8B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MGST1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ST13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACOT13 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MED7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VTI1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LEO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMEM101 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PARN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RPL36AL - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SERINC3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNHIT3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MANF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on